OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Virology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil	255
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV	245
The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2	184
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies	181
Susceptibility of White-Tailed Deer (Odocoileus virginianus) to SARS-CoV-2	178
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells	170
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?	158
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells	156
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives	143
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2	124
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus	109
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL ^pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19	97
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection	93
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice	91
Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques	90
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase	88
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity	85
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays	83
COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice	81
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication	75
Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus	75
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors	73
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity	73
African Swine Fever Virus E120R Protein Inhibits Interferon Beta Production by Interacting with IRF3 To Block Its Activation	69
SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction	69

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants	68
Structure of Nonstructural Protein 1 from SARS-CoV-2	68
The A137R Protein of African Swine Fever Virus Inhibits Type I Interferon Production via the Autophagy-Mediated Lysosomal Degradation of TBK1	67
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation	65
African Swine Fever Virus Bearing an I226R Gene Deletion Elicits Robust Immunity in Pigs to African Swine Fever	63
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway	59
A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain	59
Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 ⁺ T Cell Responses	58
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice	58
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin	56
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain	55
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells	54
Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects	53
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV	53
Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper	52
Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA	49
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity	48
Direct Evidence for Infection of Varroa destructor Mites with the Bee-Pathogenic Deformed Wing Virus Variant B, but Not Variant A, via Fluorescence In Sit	47
Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain	46
Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332	45
A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses	45
African Swine Fever Virus and Host Response: Transcriptome Profiling of the Georgia 2007/1 Strain and Porcine Macrophages	45